14-day Premium Trial Subscription Try For FreeTry Free
USANA Health (USNA) delivered earnings and revenue surprises of 0.88% and 0.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is a Surprise Coming for USANA Health Sciences (USNA) This Earnings Season?

03:19pm, Monday, 25'th Apr 2022 Zacks Investment Research
USANA Health Sciences (USNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
USANA Health Sciences (USNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
USANA Health (USNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
USANA Health (USNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Upgrades For United Parcel Service Inc (NYSE:UPS), Loop Capital upgraded the previous rating of Hold to Buy. For the fourth quarter, United Parcel Service had an EPS of $3.59, compared to year-ago qua

5 Consumer Defensive Stocks With High GF Scores

05:52pm, Tuesday, 12'th Apr 2022
In light of consumer prices continuing their record surge in March, five consumer defensive stocks with high GF Scores are The Estee Lauder Companies Inc. ( EL , Financial), Monster Beverage Corp. ( M
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market on Tuesday, April 26, 2022. Shortly follo

CTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates

09:15pm, Thursday, 31'st Mar 2022 Zacks Investment Research
CTI BioPharma (CTIC) delivered earnings and revenue surprises of -35.71% and 100%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

RVL Pharmaceuticals PLC (RVLP) Reports Q4 Loss, Misses Revenue Estimates

09:25pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
RVL Pharmaceuticals PLC (RVLP) delivered earnings and revenue surprises of 10.34% and 7.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

02:04pm, Thursday, 17'th Feb 2022
4Q results were below expectations.

USANA Health Sciences (USNA) Q4 2021 Earnings Call Transcript

12:00am, Thursday, 10'th Feb 2022 The Motley Fool
USNA earnings call for the period ending December 31, 2021.

USANA Health Sciences (USNA) Q4 2021 Earnings Call Transcript

12:00am, Thursday, 10'th Feb 2022 The Motley Fool
USNA earnings call for the period ending December 31, 2021.
USANA Health Sciences, Inc.'s (USNA) CEO Kevin Guest on Q4 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE